Persons
Webseiten-Inhalte
Cause of metastasis in prostate cancer discovered
... previously poorly understood transition from localised prostate cancer to terminal metastatic prostate cancer," says study leader Lukas Kenner (Department of Pathology at MedUni Vienna, Comprehensive Cancer Center of MedUni Vienna and University Hospital Vienna, Department of Laboratory Animal Pathology at...
https://www.meduniwien.ac.at/web/en/ueber-uns/news/default-0f889c8985-2/ursache-fuer-metastasierung-bei-prostatakrebs-entdeckt/
Cause of metastasis in prostate cancer discovered
... previously poorly understood transition from localised prostate cancer to terminal metastatic prostate cancer," says study leader Lukas Kenner (Department of Pathology at MedUni Vienna, Comprehensive Cancer Center of MedUni Vienna and University Hospital Vienna, Department of Laboratory Animal Pathology at...
https://www.meduniwien.ac.at/web/en/ueber-uns/news/default-0f889c8985-2/ursache-fuer-metastasierung-bei-prostatakrebs-entdeckt/medicine-science/
Diabetes drug as a possible treatment for prostate cancer
... regulation of metabolic processes, inflammatory reactions and cell growth as a gene activator. As the research team led by Lukas Kenner (Clinical Department of Pathology at MedUni Vienna) has now shown, it is also associated with the growth of prostate cancer. Altered growth behaviour of tumour cells The...
https://www.meduniwien.ac.at/web/en/ueber-uns/news/2025/news-in-may-2025/diabetes-drug-as-a-possible-treatment-for-prostate-cancer/medicine-science/
Diabetes drug as a possible treatment for prostate cancer
... regulation of metabolic processes, inflammatory reactions and cell growth as a gene activator. As the research team led by Lukas Kenner (Clinical Department of Pathology at MedUni Vienna) has now shown, it is also associated with the growth of prostate cancer. Altered growth behaviour of tumour cells The...
https://www.meduniwien.ac.at/web/en/ueber-uns/news/2025/news-in-may-2025/diabetes-drug-as-a-possible-treatment-for-prostate-cancer/
Prostate cancer: two proteins identified as novel markers of greater aggressiveness
... suffer an aggressive course and often fatal outcome. The joint study conducted by a research team led by Robert Wiebringhaus and supervised by Lukas Kenner from MedUni Vienna's Department of Pathology and the Department of Laboratory Animal Pathology at Vetmeduni, member of the Executive Board of the...
https://www.meduniwien.ac.at/web/en/ueber-uns/news/2021/news-im-dezember-2021/prostatakarzinom-zwei-proteine-als-neue-indikatoren-fuer-aggressiveres-verhalten-identifiziert/
Prostate cancer: two proteins identified as novel markers of greater aggressiveness
... suffer an aggressive course and often fatal outcome. The joint study conducted by a research team led by Robert Wiebringhaus and supervised by Lukas Kenner from MedUni Vienna's Department of Pathology and the Department of Laboratory Animal Pathology at Vetmeduni, member of the Executive Board of the...
https://www.meduniwien.ac.at/web/en/ueber-uns/news/2021/news-im-dezember-2021/prostatakarzinom-zwei-proteine-als-neue-indikatoren-fuer-aggressiveres-verhalten-identifiziert/medicine-science/
New approach to prostate cancer treatment
.... The research team led by Olaf Merkel, Brigitte Hantusch and Lukas Kenner (all from the Clinical Department of Pathology at MedUni Vienna) and first author Aleksandra Fesiuk (Department of Biomedical Imaging and Image-guided Therapy at MedUni Vienna) focused on the role of the thyroid hormone receptor...
https://www.meduniwien.ac.at/web/en/ueber-uns/news/2025/news-in-october-2025/new-approach-to-prostate-cancer-treatment/medicine-science/
Prostatakrebs: Neuer Ansatzpunkt für Therapie erforscht
... Prostatatumoren, besonders in einer Phase, in der aktuelle Methoden versagen. Im Zentrum der Untersuchung des Forschungsteams um Olaf Merkel, Brigitte Hantusch und Lukas Kenner (alle vom Klinischen Institut für Pathologie der MedUni Wien) sowie Erstautorin Aleksandra Fesiuk (Universitätsklinik für Radiologie...
https://www.meduniwien.ac.at/web/ueber-uns/news/2025/news-im-oktober-2025/prostatakrebs-neuer-ansatzpunkt-fuer-therapie-erforscht/
New approach to prostate cancer treatment
.... The research team led by Olaf Merkel, Brigitte Hantusch and Lukas Kenner (all from the Clinical Department of Pathology at MedUni Vienna) and first author Aleksandra Fesiuk (Department of Biomedical Imaging and Image-guided Therapy at MedUni Vienna) focused on the role of the thyroid hormone receptor...
https://www.meduniwien.ac.at/web/en/ueber-uns/news/2025/news-in-october-2025/new-approach-to-prostate-cancer-treatment/
Prostatakrebs: Neuer Ansatzpunkt für Therapie erforscht
... Prostatatumoren, besonders in einer Phase, in der aktuelle Methoden versagen. Im Zentrum der Untersuchung des Forschungsteams um Olaf Merkel, Brigitte Hantusch und Lukas Kenner (alle vom Klinischen Institut für Pathologie der MedUni Wien) sowie Erstautorin Aleksandra Fesiuk (Universitätsklinik für Radiologie...
https://www.meduniwien.ac.at/web/ueber-uns/news/2025/news-im-oktober-2025/prostatakrebs-neuer-ansatzpunkt-fuer-therapie-erforscht/medizin-wissenschaft/